Sulfamerazine EP Standard from Japan
Sulfamerazine, a short-acting sulfonamide antibiotic explicitly listed in HTS 2935.90.4200, meets European Pharmacopoeia standards for purity. Used in combination therapies for urinary tract infections, this bulk API represents a classic Chapter 29 sulfonamide classification. The product qualifies due to its specific chemical definition and anti-infective drug application.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Provide EP certificate of analysis and demonstrate US pharmacopeial equivalence for faster FDA clearance
• Declare exact isomeric purity as mixtures of isomers follow specific Chapter 29 note 2(b) classification rules
• Avoid misclassification by specifying human pharmaceutical use vs research chemical applications